UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
-
SDG 2 Zero Hunger -
SDG 3 Good Health and Well-being -
SDG 5 Gender Equality -
SDG 6 Clean Water and Sanitation -
SDG 7 Affordable and Clean Energy -
SDG 9 Industry, Innovation, and Infrastructure -
SDG 10 Reduced Inequalities -
SDG 15 Life on Land -
SDG 17 Partnerships for the Goals
Fingerprint
Dive into the research topics where Department of Oncology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
Projects
- 20 Finished
-
Investigating Novel Mechanisms and Therapeutic Targets in Igf2bp3-Pcsk9 Axis Essential for Orchestration of Hepatocellular Carcinoma Development
Yen, C.-J. (PI)
24-08-01 → 25-07-31
Project: Research project
-
-
Investigating Novel Mechanisms and Therapeutic Targets in Igf2bp3-Pcsk9 Axis Essential for Orchestration of Hepatocellular Carcinoma Development
Yen, C.-J. (PI)
22-08-01 → 23-07-31
Project: Research project
-
BDNFVal66Met protects oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer
Chen, L.-H., Lin, P. C., Yeh, Y.-M., Li, C. I., Chang, L. Y., Chang, J. Y. & Shen, M. R., 2026 Feb 18, In: Science translational medicine. 18, 837, eadx1436.Research output: Contribution to journal › Article › peer-review
-
Clinical and immunological implications of lymphocyte-activation gene 3 expression in metastatic colorectal cancer
Huang, Y. H., Wu, S. Y., Lee, C. T., Chung, B. S., Lin, P. C., Chan, R. H., Chen, P. C., Lin, B. W., Shen, M. R., Chen, S. H. & Yeh, Y. M., 2026 Apr, In: Cancer Immunology, Immunotherapy. 75, 4, 93.Research output: Contribution to journal › Article › peer-review
Open Access -
Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma (PharmacoEconomics, (2025), 43, 4, (429-440), 10.1007/s40273-024-01462-z)
Ou, H. T., Tsai, J. H., Chen, Y. L., Wu, T. I., Chen, L. J. & Yang, S. C., 2026 Feb, In: PharmacoEconomics. 44, 2, p. 261 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access